Conmed Corporation (NYSE: CNMD) has announced changes in its board of directors as Martha Aronson steps down to assume the role of president and chief executive officer at Merit Medical Systems, Inc. effective July 7, 2025. Conmed expressed gratitude for Aronson's years of service, with President and CEO Pat Beyer acknowledging her invaluable guidance and expertise. Laverne Council, chair of the board of directors, also thanked Aronson for her strategic insight and unwavering commitment to excellence during her tenure, which included serving as chair of the board since February 2016.
Conmed Corporation is a medical technology company providing devices and equipment for surgical procedures across various specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
As an investor, it's important to note the changes in leadership at Conmed and how the company will navigate this transition in the context of its financial performance and strategic direction. The market has reacted to these announcements by moving the company's shares -3.94% to a price of $52.1875. If you want to know more, read the company's complete 8-K report here.
